Lv3
342 积分 2023-11-22 加入
Type 2 diabetes prevention across the life course
8天前
已完结
Baseline and longitudinal joint associations of alcohol consumption and obesity with diabetes risk: evaluating multiplicative and additive interactions
24天前
已完结
Selective and membrane-permeable small molecule inhibitors of nicotinamide N-methyltransferase reverse high fat diet-induced obesity in mice
1个月前
已完结
A Placebo-Controlled Trial of the Oral PCSK9 Inhibitor Enlicitide
1个月前
已完结
Orforglipron, an oral small-molecule GLP-1 receptor agonist, for the treatment of obesity in people with type 2 diabetes (ATTAIN-2): a phase 3, double-blind, randomised, multicentre, placebo-controlled trial
1个月前
已完结
Orforglipron, an Oral Small-Molecule GLP-1 Receptor Agonist for Obesity Treatment
1个月前
已完结
Modifiable Risk Factors and Attributable Ischemic Heart Disease Mortality in US States, 1990-2023
1个月前
已完结
Delayed molecular aging, preservation of energy metabolism and enhanced exercise response in exercise-trained human muscle
1个月前
已完结
Patterns of One-Year Change in HbA1c and Continuous Glucose Monitoring (CGM) Metrics in Older Adults with Type 2 Diabetes
2个月前
已完结
Implementing an accurate method of standard addition (MSA) using the EZMSA Excel or R tool
2个月前
已完结
皖公网安备34019202002308
